Featured on The Today Show this morning - Fentanyl is a synthetic drug 50 times more potent than heroin, but it’s that potency that draws people to the dangerous opioid. NBC’s Kate Snow travels to Maine, where fentanyl is making rounds, to meet a dedicated group trying to beat it.
A new scholarship advancing addiction recovery in the state of Vermont has been established to support the Vermont Foundation of Recovery (VFOR) by Dominion Diagnostics, a leading national medical laboratory with a two-decade long history in the state and deep roots in its treatment and recovery community.
Dominion Diagnostics is a well-respected, trusted healthcare company with over two decades of experience and expertise delivering patient-centered drug monitoring solutions, improved treatment outcomes and actionable clinical information to inform care.
Today, Rhode Island-based medical laboratory Dominion Diagnostics joined thousands of other organizations and individuals across the globe to commemorate International Overdose Awareness Day during an event held for its employees. The day itself demands urgent action and is aimed to raise awareness of overdose and reduce the stigma of a drug-related death.
Lawrence Andrade, UC’94, has to stay sharp to outpace street-drug kingpins. As the head of R&D at Dominion Diagnostics, a clinical toxicology lab and a leading maker of drug tests, Andrade’s job is to detect when people have drugs in their system. Not only does he have to stay on top of industry trends and technology, but he also has to keep an eye on the latest drugs to hit the streets. No small task, given the U.S. opioid epidemic, which has led to an explosion of drug abuse and lent new urgency to accurate drug testing.
A pair of nationally recognized leaders for addiction treatment praised Utah for Operation Rio Grande on Thursday — while also urging state officials not to give in to community pushback that inevitably comes with efforts to address homeless issues.
Speaker Greg Hughes will host a conversation on homelessness, substance abuse and mental health with leading experts in the field. Participants will include Dominion Diagnostics Scientific Advisory Board Member David E. Smith, MD and Mary P. Hauser, MA, Vice President of Addiction Services and New Market Development for Dominion Diagnostics.